Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc logo
MIRM

Mirum Pharmaceuticals Inc (MIRM)

$18.160.77%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$17.86
Day's Range
$18.49
$13.39
52-Week Range
$30.55
1 month return9.47%
3 month return21.11%
1 year return29.44%
5 year return37.47%

Company Information

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. Mirum has submitted an NDA for maralixibat in the treatment of cholestatic pruritus in patients with ALGS. Additionally, Mirum's marketing authorization application for the treatment of pediatric patients with PFIC2 has been accepted for review (validated) by the European Medicines Agency.
OrganizationMirum Pharmaceuticals Inc
Employees194
CEOMr. Christopher Peetz
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Mirum Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 207.71%

Current

$18.16

Target

$55.88

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
13
12
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
674.7M
Book Value
$4.6
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.29
Wall Street Target Price
55.88

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
4.11
Enterprise Value
513.2M
Enterprise Value/Revenue
9.81
Enterprise Value/Ebitda
-17.08

Technicals

Beta
1.34
50 Day MA
20.34
200 Day MA
22.79

Institutional Holdings

NEA Management Company, LLC

11.36%

Deerfield Management Co

5.51%

Novo A/S

5.5%

RiverVest Venture Management LLC

5.21%

Rock Springs Capital Management LP

4.87%

BlackRock Inc

4.74%

Discover more

Frequently Asked Questions

What is Mirum Pharmaceuticals Inc share price today?

Can Indians buy Mirum Pharmaceuticals Inc shares?

How can I buy Mirum Pharmaceuticals Inc shares from India?

Can Fractional shares of Mirum Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Mirum Pharmaceuticals Inc stocks?

What are today’s High and Low prices of Mirum Pharmaceuticals Inc?

What are today’s traded volumes of Mirum Pharmaceuticals Inc?

What is today’s market capitalisation of Mirum Pharmaceuticals Inc?

What is the 52 Week High and Low Range of Mirum Pharmaceuticals Inc?

How much percentage Mirum Pharmaceuticals Inc is down from its 52 Week High?

How much percentage Mirum Pharmaceuticals Inc is up from its 52 Week low?

What are the historical returns of Mirum Pharmaceuticals Inc?

Who is the Chief Executive Officer (CEO) of Mirum Pharmaceuticals Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*